PHGE
Biomx Inc
NYSE MKT: PHGE · HEALTHCARE · BIOTECHNOLOGY
$0.85
+34.07% today
Updated 2026-04-30
Market cap
$7.54M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-37.05
Dividend yield
—
52W range
$1 – $14
Volume
0.2M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.3
Quality
C+3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$304.00
+35664.71%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-4.39M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $-134000.00 | $-357000.00 | $0.00 | — | — |
| Net income | $-28.32M | $-26.17M | $-17.73M | $-36.20M | $-13.34M |
| EPS | — | — | — | — | $-37.05 |
| Free cash flow | $-29.20M | $-21.34M | $-37.01M | $-26.39M | $-4.39M |
| Profit margin | 21,132.09% | 7,330.25% | — | — | — |
Peer comparison
Smart narrative
Biomx Inc trades at $0.85. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.
Frequently asked questions
What is Biomx Inc's stock price?
Biomx Inc (PHGE) trades at $0.85.
Is Biomx Inc overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Biomx Inc (PHGE)?
The analyst target price is $304.00, representing +35664.7% upside from the current price of $0.85.
Piotroski F-Score?
2/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio—
ROE-316.90%
Beta1.70
50D MA$4.09
200D MA$6.42
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—